Laura Donovan, MD

Background

Laura Donovan, MD, is a board-certified neurologist and neuro-oncologist who specializes in treating brain and spinal tumors.

Dr. Donovan is an associate professor in the Department of Neurology with a joint appointment in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Dr. Donovan serves as co-director of the Neuro-Oncology Program and medical director of the Brain Tumor Center at Winship Cancer Institute of Emory University.

Before joining Emory, she served as a neuro-oncologist and assistant professor in the Department of Neurology at Columbia University Irving Medical Center. She was also previously an attending physician at the James J. Peters VA Medical Center in the Bronx, New York.

Dr. Donovan earned her medical degree from Emory University School of Medicine in Atlanta. She completed her internal medicine residency at Rhode Island Hospital in Providence, followed by a neurology residency at Columbia University and a neuro-oncology fellowship at NewYork-Presbyterian/Weill Cornell in New York.

Titles & Roles

• Associate Professor, Department of Hematology and Medical Oncology

  Emory University School of Medicine
• Associate Professor, Department of Neurology

  Emory University School of Medicine
• Medical Director, Brain Tumor Center

  Winship Cancer Institute of Emory University

Education & Training

Education

• Fellowship, Neuro-Oncology, 2019

  New York Presbyterian Hospital-Columbia University Medical Center
• Residency, Neurology, 2016

  New York Presbyterian Hospital-Columbia University Medical Center
• Internship, Internal Medicine, 2013

  Brown University / Rhode Island Hospital
• Medical Education, 2012

  Emory University School of Medicine

Board Certifications

• Neurology

  American Board of Psychiatry and Neurology, 2016

Professional Memberships

• American Society for Clinical Oncology
• Society for Neuro-Oncology
• American Academy of Neurology

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.